Yu Murray (soncrib0)
Understanding the stability of drugs in a forensic toxicology setting is critical for the evaluation of drug concentrations. selleck chemical Synthetic cathinones are new psychoactive substances structurally derived from cathinone, the psychoactive component of Catha edulis ("khat"), a shrub that is indigenous to the Middle East and East Africa. Previous research has evaluated the stability of synthetic cathinones in biological matrices, including blood preserved with the combination of NaF and K2C2O4 used in gray-top tubes. However, it does not assess their stability in blood preserved with Na2EDTA, used for some clinical samples. Further, stability in unpreserved urine samples was only studied for two weeks. This research evaluates the stabilities of four Schedule I synthetic cathinones mephedrone, MDPV (3,4-methylenedioxypyrovalerone), naphyrone, and α-PVP (alpha-pyrrolidinopentiophenone) at 20°C (room temperature), 4°C (refrigerator), and -20°C (freezer). Stability was assessed in methanolic and acetonitrile solutions, astaining these cathinones should be stored in the freezer and used or tested with urgency to ensure that quantitative sample analysis is as accurate as possible in forensic casework.In the absence of an approved vaccine, developing effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals is essential to tackle the current pandemic health crisis due to the coronavirus disease 2019 (COVID-19) spread. As any traditional drug discovery program is a time-consuming and costly process requiring more than one decade to be completed, in silico repurposing of existing drugs is the preferred way for rapidly selecting promising clinical candidates. We present a virtual screening campaign to identify covalent and non-covalent inhibitors of the SARS-CoV-2 papain-like protease (PLpro) showing potential multitarget activities (i.e., a desirable polypharmacology profile) for the COVID-19 treatment. A dataset including 688 phase III and 1,702 phase IV clinical trial drugs was downloaded from ChEMBL (version 27.1) and docked to the recently released crystal structure of PLpro in complex with a covalently bound peptide inhibitor. The obtained results were analyzed by combining protein-ligand interaction fingerprint similarities, conventional docking scores, and MM-GBSA-binding free energies and allowed the identification of some interesting candidates for further in vitro testing. To the best of our knowledge, this study represents the first attempt to repurpose drugs for a covalent inhibition of PLpro and could pave the way for new therapeutic strategies against COVID-19.A rise in atmospheric CO2 levels, following years of burning fossil fuels, has brought about increase in global temperatures and climate change due to the greenhouse effect. As such, recent efforts in addressing this problem have been directed to the use of CO2 as a non-expensive and non-toxic single carbon, C1, source for making chemical products. Herein, we report on the use of tetrazolyl complexes as catalyst precursors for hydrogenation of CO2. Specifically, tetrazolyl compounds bearing P-S bonds have been synthesized with the view of using these as P∧N bidentate tetrazolyl ligands (1-3) that can coordinate to iridium(III), thereby forming heteroatomic five-member complexes. Interestingly, reacting the P,N'-bidentate tetrazolyl ligands with [Ir(C5Me5)Cl2]2 led to serendipitous isolation of chiral-at-metal iridium(III) half-sandwich complexes (7-9) instead. Complexes 7-9 were obtained via prior formation of non-chiral iridium(III) half-sandwich complexes (4-6). The complexes undergo prior P-S bond heterolye reaction by the iridium(III) catalyst precursors was studied using 1H NMR techniques. This revealed that a chiral-at-metal iridium hydride species generated in situ served as the active catalyst.Global warming is arguably the biggest scientific challenge of the twenty-first century and its environmental consequences are alre
